Structures by: Beatty A. M.
Total: 119
Isonicotinamide : form II
C6H6N2O
Crystal Growth & Design (2003) 3, 2 159
a=15.735(3)Å b=7.9976(18)Å c=9.885(3)Å
α=90.00° β=105.586(17)° γ=90.00°
2-hexenoic acid : isonicotinamide
C12H16N2O3
Crystal Growth & Design (2003) 3, 2 159
a=20.445(4)Å b=5.2309(9)Å c=23.008(4)Å
α=90.00° β=96.981(3)° γ=90.00°
Isonicotinamide : form I
C6H6N2O
Crystal Growth & Design (2003) 3, 2 159
a=10.1756(11)Å b=5.7319(6)Å c=10.0340(10)Å
α=90.00° β=98.042(7)° γ=90.00°
4-Chlorobenzamide : 3-Dimethylaminobenzoic acid
C16H17ClN2O3
Crystal Growth & Design (2003) 3, 2 159
a=7.1732(13)Å b=8.3689(17)Å c=12.997(3)Å
α=88.638(4)° β=80.875(4)° γ=77.463(4)°
Isonicotinamide : 4-nitrobenzoic acid
C13H11N3O5
Crystal Growth & Design (2003) 3, 2 159
a=20.512(4)Å b=5.1675(10)Å c=23.694(5)Å
α=90.00° β=90.66(3)° γ=90.00°
3,5-dinitrobenzoic acid : isonicotinamide : 4-toluic acid
C21H18N4O9
Crystal Growth & Design (2003) 3, 2 159
a=7.7628(11)Å b=8.7216(12)Å c=15.7426(19)Å
α=93.483(2)° β=98.981(3)° γ=93.913(2)°
2-amino-5-nitropyrimidine : 2-amino-3-nitropyridine
C9H9N7O4
Crystal Growth & Design (2003) 3, 2 159
a=11.786(3)Å b=5.1614(13)Å c=19.975(5)Å
α=90.00° β=95.275(5)° γ=90.00°
4-Chlorobenzamide : 3,5-Dinitrobenzoic acid
C14H10ClN3O7
Crystal Growth & Design (2003) 3, 2 159
a=7.2458(11)Å b=8.6260(13)Å c=13.2806(19)Å
α=92.566(3)° β=101.875(3)° γ=109.472(3)°
2(4-Chlorobenzamide) : Fumaric acid
C18H16Cl2N2O6
Crystal Growth & Design (2003) 3, 2 159
a=9.2674(8)Å b=10.1386(9)Å c=10.4805(10)Å
α=86.428(6)° β=72.174(6)° γ=89.506(7)°
C12H12NO,C5H3N2O4
C12H12NO,C5H3N2O4
Crystal Growth & Design (2009) 9, 11 4595
a=24.7179(15)Å b=15.4064(11)Å c=12.8407(9)Å
α=90.00° β=101.766(2)° γ=90.00°
C14H16N3O5
C14H16N3O5
Crystal Growth & Design (2009) 9, 11 4595
a=8.9976(7)Å b=13.1796(11)Å c=12.7539(11)Å
α=90.00° β=108.714(4)° γ=90.00°
C14H17N3O4
C14H17N3O4
Crystal Growth & Design (2009) 9, 11 4595
a=8.9654(7)Å b=12.6596(8)Å c=12.7444(9)Å
α=90.00° β=107.987(3)° γ=90.00°
C8H11FN,C5H3N2O4
C8H11FN,C5H3N2O4
Crystal Growth & Design (2009) 9, 11 4595
a=16.4915(11)Å b=6.5669(4)Å c=13.6542(9)Å
α=90.00° β=118.910(3)° γ=90.00°
C17H17N3O4
C17H17N3O4
Crystal Growth & Design (2009) 9, 11 4595
a=6.6338(4)Å b=7.6444(5)Å c=8.6996(8)Å
α=113.502(5)° β=102.074(5)° γ=102.532(4)°
C24H42B2ORu2
C24H42B2ORu2
Journal of the American Chemical Society (2003) 125, 16367-16382
a=8.3722(4)Å b=19.8606(8)Å c=15.1043(6)Å
α=90.00° β=95.6380(10)° γ=90.00°
(E)-2-Butenoic acid 4-amino-4-oxo ethyl ester
C6H9NO3
Journal of the American Chemical Society (2002) 124, 11315-11323
a=20.880(5)Å b=3.9280(10)Å c=8.610(2)Å
α=90.00° β=90.00° γ=90.00°
C24H43B3O2Ru2
C24H43B3O2Ru2
Journal of the American Chemical Society (2002) 124, 10280-10281
a=11.4297(7)Å b=14.8019(9)Å c=15.4447(9)Å
α=90.00° β=93.0530(10)° γ=90.00°
C30H49B4Rh3
C30H49B4Rh3
Organometallics (2002) 21, 23 5029
a=10.9363(14)Å b=16.767(2)Å c=17.995(2)Å
α=85.271(2)° β=89.700(2)° γ=71.045(2)°
C13H23B4CoFeO3
C13H23B4CoFeO3
Organometallics (2002) 21, 14 2821
a=9.2109(6)Å b=16.4715(11)Å c=11.7973(8)Å
α=90.00° β=101.2170(10)° γ=90.00°